Low levels of a substance, acetyl-L-carnitine, in the blood are associated with depression. Could this "mood mirror" be a cure for the blues?
How our brains blend cues from multiple senses to estimate our speed and position in space depends on where we are and how fast we seem to be moving.
What if you could stitch together single cells any way you wanted to? Potential medical and even industrial applications abound.
A group of researchers have developed an imaging method to show the brain in motion.
A set of structurally similar proteins can activate a receptor for nicotine on immune cells, resulting in a dialing down of inflammation.
Stanford's Karl Deisseroth has won the 2018 Kyoto Prize in applied technology for his invention and application of optogenetics.
In each of our abdomens sit trillions of microbes, but a bout of diarrhea can induce a lasting round of gut-bug disruption, new research indicates.
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
A hitherto unheralded set of telltale enzymes may prove to be perfect targets for shooting down a gang of nasty bacterial pathogens collectively called S. aureus.
The discovery, in mice, of a pair of nerve clusters regulating fearful versus bold responses to a visual threat could help people with excessive anxiety, phobias or post-traumatic stress disorder lead more normal lives.
What makes breathing possible is a thin coating of a soaplike film, or surfactant, that lowers the tension of the lung’s inner surface. Premature babies and adults with lung injuries are short on surfactant, and replacing it has been prohibitively pricey. That may be about to change.
In a JAMA opinion piece, Gary Peltz and Tom Sudhof argue for policymakers and health leaders to combat opioid addictions early.
Older people are more susceptible to infection, cancer, and autoimmunity than younger people. This may be the result of our immune cells' receiving increasingly random marching orders as we age.
In an interview in the journal Neuron, Stanford's Rob Malenka holds forth on a wide range of subjects stretching from reflections on his own career trajectory to his approach to boosting those of his trainees to the future of neuroscience itself.
Stanford scientists have figured out a way to convert common brewer’s yeast into an efficient factory for making a non-narcotic cough medicine that occurs naturally only in opium poppies.
Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.